However, our analysis showed that the VEGF-A ACGG haplotype from -2578, -1498, -1154, and -634 was significantly associated with an increased risk of recurrence in RCC patients (OR = 3.34, 95% CI = 1.03–10.91). This evidence concerns the gene VEGFA and renal cell carcinoma.